Robust Bayesian hierarchical models for basket trials enabling joint evaluation of toxicity and efficacy
Statistical Methods in Medical Research · 2026
DOI: 10.1177/09622802261465336 ↗Kurz gefasst
Fachartikel in der Zeitschrift Statistical Methods in Medical Research, 2026. Verfasst von Zhi Cao und 2 weiteren Autor:innen. Beteiligte Einrichtung: MRC Biostatistics Unit, University of Cambridge, Cambridge, UK. Hauptthemen laut MEDLINE: Models, Statistical, Clinical Trials as Topic. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Research UK, Medical Research Council, National Institute for Health and Care Research.
Abstract (Originalsprache)
Basket trials have gained increasing attention for their efficiency, as multiple patient subgroups are evaluated simultaneously. Conducted basket trials focus primarily on establishing the early efficacy of a treatment, yet continued monitoring of toxicity is essential. In this article, we propose two Bayesian hierarchical models that enable bivariate analyses of toxicity and efficacy, while accounting for heterogeneity present in the treatment effects across patient subgroups. Specifically, one assumes the subgroup-specific toxicity and efficacy treatment effects, as a parameter vector, can be exchangeable or non-exchangeable; the other allows either the toxicity or efficacy parameters specific to the subgroups, to be exchangeable or non-exchangeable. The bivariate exchangeability and non-exchangeability distributions introduce a correlation parameter between treatment effects, while we stipulate a zero correlation when only toxicity or efficacy parameters are exchangeable. Simulation results show that our models perform robustly under different scenarios compared to the standard Bayesian hierarchical model and the stand-alone analyses, especially in producing higher power when the subgroup-specific effects are exchangeable in toxicity or efficacy only. When considerable correlation between the toxicity and efficacy effects exists, our methodology gives small error rates and greater power than alternatives that analyse toxicity and efficacy by parts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- MRC Biostatistics Unit, University of Cambridge, Cambridge, UK.
- Department of Mathematical Sciences, University of Bath - Claverton Down Campus, Bath, UK.
ORCID-Profile: Zhi Cao, Pavel Mozgunov, Haiyan Zheng
Förderung
- Cancer Research UK
- Medical Research Council
- National Institute for Health and Care Research
Zitieren
APA
Cao, Z., Mozgunov, P., & Zheng, H. (2026). Robust Bayesian hierarchical models for basket trials enabling joint evaluation of toxicity and efficacy. Statistical Methods in Medical Research. https://doi.org/10.1177/09622802261465336
Vancouver
Cao Z, Mozgunov P, Zheng H. Robust Bayesian hierarchical models for basket trials enabling joint evaluation of toxicity and efficacy. Statistical Methods in Medical Research. 2026. doi:10.1177/09622802261465336
BibTeX
@article{Cao2026,
author = {Cao, Zhi and Mozgunov, Pavel and Zheng, Haiyan},
title = {Robust Bayesian hierarchical models for basket trials enabling joint evaluation of toxicity and efficacy},
journal = {Statistical Methods in Medical Research},
year = {2026},
doi = {10.1177/09622802261465336}
}
EUVIMED